Paper of the Month - Volume 28 Issue 1

0 rating

Do the Drugs Used to Treat Rheumatic Disorders Induce Bone Fragility? A Review

Susanna vid Streym Thomsen, RN, Peter Vestergaard, MD, PhD, DrMedSc

Rheumatic disorders are linked to immuno-logical processes in the body; therefore, drugs used to treat these disorders may interfere with the immune system. The immune system shares several signaling mechanisms with bone cells, both directly via cytokines and prostaglandins, and indirectly via vitamin D, which is also an active immunological substance. As a result, drugs used to modulate the immune response may interfere with bone mineral density (BMD), bone biomechanical competence, and the risk of fractures [1–3].



READER POLL

Rheum poll 1
Which of the following tests for latent TB infection do you initially perform prior to starting anti-TNF or other immunosuppressive therapies in your patients?






Powered by NetPolls

SUBMIT AN ARTICLE